12:09 O03 In vitro validation of the novel anti-CD19 and anti-CD38 UniCAR T cell therapy for refractory iTTP patients – Lisa Vermeersch

Belgium

Thursday, 27 November
Oral Presentations Basic Science
Date: 27 Nov 2025Time: 11:45 - 12:45
Chairs: Sandrine Horman & Cécile Oury

Home › 12:09 O03 In vitro validation of the novel anti-CD19 and anti-CD38 UniCAR T cell therapy for refractory iTTP patients - Lisa Vermeersch